174 related articles for article (PubMed ID: 36300810)
1. Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune Cells.
Zhan M; Qiu J; Fan Y; Chen L; Guo Y; Wang Z; Li J; Majoral JP; Shi X
Adv Mater; 2023 Jan; 35(3):e2208277. PubMed ID: 36300810
[TBL] [Abstract][Full Text] [Related]
2. Selenopeptide Nanomedicine Activates Natural Killer Cells for Enhanced Tumor Chemoimmunotherapy.
Wei Z; Yi Y; Luo Z; Gong X; Jiang Y; Hou D; Zhang L; Liu Z; Wang M; Wang J; Guo R; Yang J; Wang L; Wang H; Zhao Y
Adv Mater; 2022 Apr; 34(17):e2108167. PubMed ID: 35132688
[TBL] [Abstract][Full Text] [Related]
3. Core-shell tecto dendrimer-mediated cooperative chemoimmunotherapy of breast cancer.
Song C; Zhan M; Ouyang Z; Yao Y; Gao Y; Shen M; Shi X
J Control Release; 2023 Jun; 358():601-611. PubMed ID: 37201799
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic phosphorous dendron micelles co-deliver microRNA inhibitor and doxorubicin for augmented triple negative breast cancer therapy.
Chen L; Zhan M; Li J; Cao L; Sun H; Laurent R; Mignani S; Caminade AM; Majoral JP; Shi X
J Mater Chem B; 2023 Jun; 11(24):5483-5493. PubMed ID: 36444746
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
[TBL] [Abstract][Full Text] [Related]
7. Transformable prodrug nanoplatform
Yang W; Yi J; Zhu R; Guo Y; Zhang K; Cao Y; Li X; Zhang J; Zhang Z; Li Y; Chen X
Theranostics; 2023; 13(6):1906-1920. PubMed ID: 37064869
[No Abstract] [Full Text] [Related]
8. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy.
Kim J; Shim MK; Moon Y; Kim J; Cho H; Yun WS; Shim N; Seong JK; Lee Y; Lim DK; Kim K
J Nanobiotechnology; 2024 Mar; 22(1):109. PubMed ID: 38481326
[TBL] [Abstract][Full Text] [Related]
10. Brain Delivery of Biomimetic Phosphorus Dendrimer/Antibody Nanocomplexes for Enhanced Glioma Immunotherapy via Immune Modulation of T Cells and Natural Killer Cells.
Peng Y; Zhan M; Karpus A; Zou Y; Mignani S; Majoral JP; Shi X; Shen M
ACS Nano; 2024 Apr; 18(14):10142-10155. PubMed ID: 38526307
[TBL] [Abstract][Full Text] [Related]
11. Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy.
Liang Q; Lan Y; Li Y; Cao Y; Li J; Liu Y
Eur J Pharm Biopharm; 2022 Aug; 177():260-272. PubMed ID: 35863668
[TBL] [Abstract][Full Text] [Related]
12. Tandem Chemoimmunotherapy by a Cascade-Responsive Molecular Prodrug.
Yang Z; Luo X; Lin Y; Huang J; Lin H; Gao J
ACS Chem Biol; 2022 Apr; 17(4):762-767. PubMed ID: 35285234
[TBL] [Abstract][Full Text] [Related]
13. Combinational Chemoimmunotherapy for Breast Cancer by Codelivery of Doxorubicin and PD-L1 siRNA Using a PAMAM-Incorporated Liposomal Nanoplatform.
Hu Q; Yao J; Wang X; Wang Y; Fu X; Ma J; Lin H; Xu J; Shen L; Yu X
ACS Appl Mater Interfaces; 2022 Feb; 14(7):8782-8792. PubMed ID: 35138103
[TBL] [Abstract][Full Text] [Related]
14. GE11-modified carboxymethyl chitosan micelles to deliver DOX·PD-L1 siRNA complex for combination of ICD and immune escape inhibition against tumor.
Song P; Wang B; Pan Q; Jiang T; Chen X; Zhang M; Tao J; Zhao X
Carbohydr Polym; 2023 Jul; 312():120837. PubMed ID: 37059562
[TBL] [Abstract][Full Text] [Related]
15. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
[TBL] [Abstract][Full Text] [Related]
16. NIR-responsive and lectin-binding doxorubicin-loaded nanomedicine from Janus-type dendritic PAMAM amphiphiles.
Sun L; Ma X; Dong CM; Zhu B; Zhu X
Biomacromolecules; 2012 Nov; 13(11):3581-91. PubMed ID: 23017146
[TBL] [Abstract][Full Text] [Related]
17. Phosphorus dendron nanomicelles as a platform for combination anti-inflammatory and antioxidative therapy of acute lung injury.
Li J; Chen L; Li C; Fan Y; Zhan M; Sun H; Mignani S; Majoral JP; Shen M; Shi X
Theranostics; 2022; 12(7):3407-3419. PubMed ID: 35547777
[No Abstract] [Full Text] [Related]
18. Codelivery of Anti-PD-1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual-Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy.
Su Z; Xiao Z; Wang Y; Huang J; An Y; Wang X; Shuai X
Small; 2020 Feb; 16(7):e1906832. PubMed ID: 31990457
[TBL] [Abstract][Full Text] [Related]
19. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
[TBL] [Abstract][Full Text] [Related]
20. Homotypic targeted nanoplatform enable efficient chemoimmunotherapy and reduced DOX cardiotoxicity in chemoresistant cancer via TGF-β1 blockade.
Li N; Zhang T; Wang R; Sun Y; Chu L; Lu X; Sun K
J Control Release; 2023 Sep; 361():147-160. PubMed ID: 37536544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
